Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.
about
Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income countryPrevalence and factors associated with renal dysfunction among HIV-infected patientsScreening for chronic kidney disease in HIV-infected patients.Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study.Prevalence and risk factors associated to chronic kidney disease in HIV-infected patients on HAART and undetectable viral load in BrazilHIV and proteinuria in an injection drug user population.WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients.Nephrotoxicity of HAARTSex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count.Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis.Is Abnormal Urine Protein/Osmolality Ratio Associated with Abnormal Renal Function in Patients Receiving Tenofovir Disoproxil Fumarate?Prevalence and predictors of chronic kidney disease in newly diagnosed human immunodeficiency virus patients in Owerri, Nigeria.Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010.Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients.Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir.A look at risk factors of proteinuria in subjects without impaired renal filtration function in a general population in Owerri, NigeriaRenal dysfunction in the setting of HIV/AIDS.Renal toxicity associated with antiretroviral therapy.Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.Risk of coronary heart disease in patients with HIV infection.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionPrevalence of renal disease within an urban HIV-infected cohort in northern Italy.A randomized clinical trial comparing metabolic parameters after 48 weeks of standard- and low-dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV-infected South African patients.Renal manifestations of HIV during the antiretroviral era in South Africa: a systematic scoping review.High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis.Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patientsThe metabolic syndrome and renal function in an African cohort infected with human immunodeficiency virus
P2860
Q28541930-885E28FC-39BF-40B3-8558-8CFE151FC35DQ30484533-1B46AF5E-D85D-442D-BBD7-06B9BC712D11Q33639802-9CCA2470-37A5-481F-83B9-8753D5CFFAACQ34001926-FE7DCD2C-745E-4F11-A2F3-64F6D89BCAC9Q34055914-B78B2154-34AD-4C61-8610-8650C1DF3B37Q34281398-8C86A498-8F6C-4A55-9801-5DE897D980B8Q35040358-2DB42116-317E-4D3E-9E11-8930D68802B7Q35167944-8A379CEC-5402-4C4C-864E-AA265A5052A8Q35492587-34EEE67E-1B7A-4C92-B4AC-C251F8516F3AQ36275957-74AD2BC7-B2DB-447B-A732-7763CAE0B204Q36576316-9549B152-0D41-4C57-A001-E1153D83D4C3Q36580386-3BBD88BC-DCB7-4111-8E38-0F03E84356C7Q36723349-3500B5B1-8006-4C61-A8F8-1AE7BFA18F32Q36844074-BC237CB8-0392-4C0F-A472-531B3F769EAAQ36903905-220D062F-C789-40D4-AA9F-36442B0781A5Q36988748-45840CD9-FC24-4E55-A9E9-EBA260B46AD7Q37131280-0C9C46EA-FFDA-4159-B866-5EAA9C3EFCA6Q38019428-B317521D-7194-4C6A-9B61-2A9C36CDB18DQ38031028-9D9311AE-F593-47A3-8A64-A980763BA2FBQ38222708-99008D43-3EA1-4251-B4C2-7DECEA49B5D6Q38261508-23DA759A-6BE4-4689-9B0F-5166627F1E6AQ38749963-8EC05CBF-E850-489A-9BFB-CB19732C0597Q40113698-22342E38-74CD-40B7-99AD-032845CE6202Q42249729-5EABBA3E-C385-4119-9B2C-4757B6DE5614Q42377428-215AA87E-2BC3-4542-94BA-CC0A20565A9DQ44307756-772008AA-C1A5-44B0-9019-1243796641C4Q46811196-9B36D56A-EE07-4313-979F-B5B72DD96BEFQ53692625-E38D8586-7E09-4500-8AFB-F35847EF68A0Q56985092-E6890ABB-8CE1-4F98-97F6-02E8454F591BQ57821981-314F76FD-4A46-4605-AE06-21B8DCA4BAB4
P2860
Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Factors associated with renal ...... active antiretroviral therapy.
@en
Factors associated with renal ...... active antiretroviral therapy.
@nl
type
label
Factors associated with renal ...... active antiretroviral therapy.
@en
Factors associated with renal ...... active antiretroviral therapy.
@nl
prefLabel
Factors associated with renal ...... active antiretroviral therapy.
@en
Factors associated with renal ...... active antiretroviral therapy.
@nl
P2093
P2860
P921
P1433
P1476
Factors associated with renal ...... active antiretroviral therapy.
@en
P2093
D Nurutdinova
E T Overton
W Seyfried
P2860
P304
P356
10.1111/J.1468-1293.2009.00693.X
P577
2009-03-11T00:00:00Z